read online | #116 - 12/2017
Melanoma Bridge 2017
Immunotherapy combinations in melanoma
Michael Postow of Memorial Sloan Kettering Cancer Center on combinations and doses in immunotherapy of melanoma.
The Obesity Paradox in melanoma
Michael A. Davies of MD Anderson Cancer Center, Texas on the clinical significance of obesity in advanced melanoma.
Immunotherapy for cancer: the role of microbiota
Thomas F. Gajewski of the University of Chicago Medicine on tumor and host genomics regulating immunotherapy efficacy.
Immunotherapy for cancer, a real turning point
What did we learn about melanoma in the last years and how could we use this knowledge? Let’s hear Ena Wang of Sidra Medical Centre, Doha.
Lymphadenectomy in sentinel node-positive melanoma:NO
Jeffrey E. Gershenwald of the Department of Surgical Oncology of The University of Texas MD Anderson Cancer Center.
Lymphadenectomy in sentinel node-positive melanoma:YES
We met in Naples Merrick Ross of the Department of Surgical Oncology of The University of Texas MD Anderson Cancer Center.
@Oncoinfo_it - 24 set 2017
Great meeting about #Immunotherapy in #melanoma #bridge2017 @PAscierto @3PSolution
@Oncoinfo_it - 2 dic 2017
Here comes the next generation of clinical trials @BernardAFox at #bridge2017 #melanoma @PAscierto @OmidHamidMD
A beautiful #bridge2017 congress on #Immunotherapy #melanoma for @OmidHamidMD @PAscierto @BernardAFox @3PSolution
Si ringrazia, per il supporto non condizionato a questo numero:
UNA PUBBLICAZIONE DE IL PENSIERO SCIENTIFICO EDITORE
la mia iscrizione
oncoinfo.it 2017 © Think2it | All rights reserved